戻る Agenda
Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Session Chair(s)
Earl Seltzer, MBA
Senior Director, Partnerships and Innovation
CTI, United States
Having a product approved does not guarantee uptake post approval. This session will provide recommendations to insert evidence generating diagnostic strategies earlier in clinical development and will discuss case studies on different tactics.
Learning Objective : Identify areas of opportunity to insert diagnostic strategies to generate real-world evidence into clinical development plans; Assess existing clinical development plans for new therapeutics and integrate evidence collection to support post approval product uptake.
Speaker(s)
Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Patrick Short
Sano Genetics, United Kingdom
Chief Executive Officer
Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Keith Hanigan
Blueprint Medicines , United States
US Head of Precision Medicine
Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Jeffrey Shuster, PhD
Covance Central Laboratory Services, United States
Director, Companion Diagnostics